|Articles|January 3, 2019
Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 3
Related Content
Trending on Pharmaceutical Technology
1
Ask the Expert: Complying with Standards
2
What Does Overton's FDA Nomination Mean for Drug Reviews?
3
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
4
How Do CDMOs Scale High-Concentration Biologic Formulations?
5